Monografie
Role of the transcriptional coactivators Megakaryoblastic Leukemia Proteins 1 and 2 in tumorigenesis
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Diss., 2014
- Identifier
-
1078852200
Thema
Krebs; Onkologie; Hochschulschrift
Beteiligte Personen und Organisationen
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:55 MEZ
Objekttyp
- Monografie
Ähnliche Objekte (12)
Targeting the actin cytoskeleton with natural compounds : elucidating the underlying mechanism of apoptosis induction
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
Loss of mitochondrial thioredoxin reductase delays angiogenic switch and impairs tumour growth
The V-ATPase inhibitor archazolid : Impact on anoikis resistance in metastatic cancer cells
Targeting cyclin dependent kinase 5 in hepatocellular carcinoma : a novel therapeutic approach
Untersuchungen zur zellulären Seneszenz Cathepsin X-defizienter Zellen
Evaluation of the natural compound Archazolid and its target V-ATPase for treatment of T-cell acute lymphoblastic leukemia & Evaluation of Cdk5 as target for breast cancer treatment
Novel treatment strategies and mechanisms of actin binding compounds in cancer therapy
The myxobacterial acetyl-CoA carboxylase inhibitor Soraphen A as a novel anti-metastatic and anti-proliferative agent
Inhibition of the V-ATPase - A novel strategy to prevent epithelial-mesenchymal transition and cancer stem cell formation
Targeting V-ATPase influences cancer cell cholesterol metabolism and biophysical properties - a new option for HCC therapy
Targeting the endolysosomal system of cancer cells by inhibition of V-ATPase and TPC function
Targeting the actin cytoskeleton with natural compounds : elucidating the underlying mechanism of apoptosis induction
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
Loss of mitochondrial thioredoxin reductase delays angiogenic switch and impairs tumour growth
The V-ATPase inhibitor archazolid : Impact on anoikis resistance in metastatic cancer cells
Targeting cyclin dependent kinase 5 in hepatocellular carcinoma : a novel therapeutic approach
Untersuchungen zur zellulären Seneszenz Cathepsin X-defizienter Zellen
Evaluation of the natural compound Archazolid and its target V-ATPase for treatment of T-cell acute lymphoblastic leukemia & Evaluation of Cdk5 as target for breast cancer treatment
Novel treatment strategies and mechanisms of actin binding compounds in cancer therapy
The myxobacterial acetyl-CoA carboxylase inhibitor Soraphen A as a novel anti-metastatic and anti-proliferative agent
Inhibition of the V-ATPase - A novel strategy to prevent epithelial-mesenchymal transition and cancer stem cell formation
Targeting V-ATPase influences cancer cell cholesterol metabolism and biophysical properties - a new option for HCC therapy
Targeting the endolysosomal system of cancer cells by inhibition of V-ATPase and TPC function
Targeting the actin cytoskeleton with natural compounds : elucidating the underlying mechanism of apoptosis induction
Preclinical characterization of the myxobacterial compound pretubulysin as novel vascular disrupting agent
Loss of mitochondrial thioredoxin reductase delays angiogenic switch and impairs tumour growth
The V-ATPase inhibitor archazolid : Impact on anoikis resistance in metastatic cancer cells
Targeting cyclin dependent kinase 5 in hepatocellular carcinoma : a novel therapeutic approach
Untersuchungen zur zellulären Seneszenz Cathepsin X-defizienter Zellen
Evaluation of the natural compound Archazolid and its target V-ATPase for treatment of T-cell acute lymphoblastic leukemia & Evaluation of Cdk5 as target for breast cancer treatment
Novel treatment strategies and mechanisms of actin binding compounds in cancer therapy
The myxobacterial acetyl-CoA carboxylase inhibitor Soraphen A as a novel anti-metastatic and anti-proliferative agent
Inhibition of the V-ATPase - A novel strategy to prevent epithelial-mesenchymal transition and cancer stem cell formation
Targeting V-ATPase influences cancer cell cholesterol metabolism and biophysical properties - a new option for HCC therapy